Vaccination against drug resistance in HIV infection

Expert Review of Vaccines

Volumn 7, Issue 1, 2008, Pages 131-145

  Boberg, Andreas ^a   Isaguliants, Maria ^a,b  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

Author keywords

Antigen retargeting; Cytotoxic T lymphocyte; DNA vaccine; Drug resistance; Epitope; Highly active antiretroviral therapy; HIV 1; Human lymphocyte antigen binding; Immune hierarchy; Immunity to mutations; Immunogen design; Processing; Therapeutic vaccination

Indexed keywords

ANTIRETROVIRUS AGENT; ARGINYLTYROSYLARGINYLLEUCYLLYSYLHISTIDYLLEUCYLVALYLTRYPTOPHAN; DENDRITIC CELL VACCINE; DNA VACCINE; EPITOPE; GLUTAMINYLTYROSYLARGINYLLEUCYLLYSYLHISTIDYLISOLEUCYLVALYLTRYPTOPHAN; HLA ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; ISOLEUCYLSERYLPROLYLARGINYLTHREONYLLEUCYLASPARAGINYLALANYLTRYPTOPHAN; LEUCYLARGINYLTRYPTOPHYLGLYCYLPHENYLALANYLTHREONYLTHREONYL PROLYLASPARTYLLYSYLLYSINE; LIPOPEPTIDE; LYSYLTYROSYLARGINYLLEUCYLLYSYLHISTIDYLLEUCYLVALYLTRYPTOPHAN; NAKED DNA; NEF PROTEIN; PROTEASOME; RALTEGRAVIR; RECOMBINANT DNA; RECOMBINANT GLYCOPROTEIN GP 120; REV PROTEIN; SERYLLEUCYLPHENYLALANYLASPARAGINYLTHREONYLVALYLALANYLVALYLLEUCINE; SERYLPROLYLALANYLISOLEUCYLPHENYLALANYLGLUTAMINYLSERYLSERYLMETHIONINE; SERYLVALYLTYROSYLASPARAGINYLTHREONYLVALYLALANYLTHREONYLLEUCINE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIF PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS VECTOR; VPR PROTEIN;

ALLELE; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DNA IMMUNIZATION; DRUG EFFECT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNIZATION; MUTATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SURVIVAL TIME; TH1 CELL; UNSPECIFIED SIDE EFFECT; VACCINATION; VIRUS IDENTIFICATION; VIRUS INHIBITION; VIRUS LOAD; VIRUS RECOMBINANT; VIRUS REPLICATION;

AIDS VACCINES; ANIMALS; ANTI-HIV AGENTS; CROSS REACTIONS; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, VIRAL; HIV; HIV INFECTIONS; HUMANS; MICE; MUTATION;

EID: 40549120629     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.7.1.131     Document Type: Review

References (122)